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Summary
Background Mortality due to enteric infections is projected to increase because of global warming; however, the 
different temperature sensitivities of major enteric pathogens have not yet been considered in projections on a global 
scale. We aimed to project global temperature-attributable enteric infection mortality under various future scenarios 
of sociodemographic development and climate change.
Methods In this modelling study, we generated global projections in two stages. First, we forecasted baseline mortality 
from ten enteropathogens (non-typhoidal salmonella, Shigella, Campylobacter, cholera, enteropathogenic 
Escherichia coli, enterotoxigenic E coli, typhoid, rotavirus, norovirus, and Cryptosporidium) under several future 
sociodemographic development and health investment scenarios (ie, pessimistic, intermediate, and optimistic). We 
then estimated the mortality change from baseline attributable to global warming using the product of projected 
annual temperature anomalies and pathogen-specific temperature sensitivities.
Findings We estimated that in the period 2080–95, the global mean number of temperature-attributable deaths due to 
enteric infections could be as low as 6599 (95% empirical CI 5441–7757) under the optimistic sociodemographic 
development and climate change scenario, or as high as 83 888 (67 760–100 015) under the pessimistic scenario. Most 
of the projected temperature-attributable deaths were from shigellosis, cryptosporidiosis, and typhoid fever in 
sub-Saharan Africa and South Asia. Considerable reductions in the number of attributable deaths were from viral 
infections, such as rotaviral and noroviral enteritis, which resulted in net reductions in attributable enteric infection 
mortality under optimistic scenarios for Latin America and the Caribbean and East Asia and the Pacific.
Interpretation Temperature-attributable mortality could increase under warmer climate and unfavourable 
sociodemographic conditions. Mitigation policies for limiting global warming and sociodemographic development 
policies for low-income and middle-income countries might help reduce mortality from enteric infections in the 
future.
Funding Japan Society for the Promotion of Science, Japan Science and Technology Agency, and Spanish Ministry of 
Economy, Industry, and Competitiveness.
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Introduction
Enteric infections cause a substantial burden of ill-health 
in low-income and middle-income countries (LMICs),1 
and they are likely to remain a public health risk under 
climate change, due to the increase in ambient 
temperature in particular.2 This expectation can be 
explained by the influence of temperature on the growth 
and survival of enteropathogens, which cause enteric 
infections.3–5 Some of them can grow, proliferate, and 
remain infective under warm temperatures in water, 
food, and other surfaces.6–8 They can also accumulate 
under dry conditions, which very warm temperatures 
might contribute to.9 High temperatures might also alter 
water availability, affecting access to clean and drinking 
water, as well as proper handwashing and hygiene.10–12 
Moreover, warmer temperatures were observed to 
increase pathogen loads in animal hosts and possibly 
prolong transmissions.13
Early global projections of enteric infections related 
to temperature change, based on a limited set of 
exposure-response estimates, reported that risks were 
higher under future scenarios with high temperatures and 
in countries with low incomes.14 Using this previous 
approach, the number of global temperature-related excess 
deaths was predicted to be in the range of 21 000–68 000 
in 2030, but to slightly decrease to a value in the range of 
15 000–49 000 by 2050.15 Similarly, temperature-related 
infectious gastro enteritis cases in Japan were projected to 
decline by 0∙8–9∙1% in 2090–99, compared with the 
amount in 2010–19, with the greatest reduction occurring 
in a future with high radiative forcing (ie, a large change in 
global energy balance brought about by forcing agents like 
greenhouse gases that contribute to climate change).16 This 
net reduction was attributed to a probable diminishing of 
cold-related morbidity that outweighed the heat-related 
increases.16 The authors suggested that cold-related 
morbidity could be largely due to viral infections that have 
negative associations with ambient temperature.17,18
Because the previous projections did not have any taxa-
specific or pathogen-specific analyses, they could not 
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account for the different temperature sensitivities of 
various enteropathogens. A 2016 study in children in an 
Indian city approached this issue by modelling all-cause 
diarrhoea cases categorised into three major pathogens.3 
With use of an agent-based modelling framework for 
pathogen ingestion via contaminated drinking water, the 
study reported that a temperature rise in the future would 
decrease the prevalence of rotavirus by 10∙5% and would 
increase the prevalence of Cryptosporidium by 9∙9% and 
Escherichia coli by 6∙3% in 2080–99 relative to the 2011–30 
baseline.3 Aggregating the diarrhoea cases together 
resulted in a net increase of 6∙4% per 1°C temperature 
rise because of a combined increase in the prevalence of 
cryptosporidiosis and E coli enteritis.3 Although this 
finding is notable, there are additional important 
pathogens known to cause enteric infections, such 
as Shigella, typhoidal salmonella, Vibrio cholerae, and 
norovirus, which also have varying temperature sensi-
tivities,19,20 and are yet to be accounted for in projection 
studies.
In this Article, we aimed to use an extended pathogen-
specific approach to undertake future projections of 
temperature-attributable mortality due to enteric 
infections. Our study is based on global mortality due to 
enteric infections from specific pathogens previously 
estimated by the Institute for Health Metrics and 
Evaluation-Global Burden of Diseases, Injuries, and 
Risk Factors Study (IHME-GBD).20 We refined these 
estimates by considering the effects of temperature on 
enteric infection under future scenarios of climate 
change, sociodemographic development, and health 
investments. The additional dimensions considered in 
our analysis could provide evidence underpinning the 
mitigation of greenhouse gas emis sions at the global 
level and the promotion of adaptation strategies for 
health, particularly in LMICs.21
Methods
Study design
We projected global temperature-attributable mortality 
from enteric infec tions in two stages. First, we forecasted 
pathogen-specific mortality due to enteric infections 
according to sociodemographic and health drivers 
without considering temperature. Second, we estimated 
the temperature-attributable mortality per pathogen on 
the basis of projected temperature anomalies and 
pathogen-specific temperature sensitivities.
Enteric infection mortality forecasting
We adopted Foreman and colleagues’ method for 
forecasting pathogen-specific mortality using the socio-
demographic index (SDI), trend, and scalar of risk 
factors.22 A linear mixed model was used, with the SDI 
and trend as fixed effects, and the country, age, and 
pathogen as random effects:
where the logarithm of projected annual enteric infection 
mortality rate D is expressed as an additive relationship 
between the intercept α, the SDI (as a piecewise-linear 
function with a cutoff value of 0∙8), the year t, and a 
scalar of risk factors S (as an offset). The symbol r denotes 
the pathogen, l the country, and a the age group, and 
Research in context
Evidence before this study
We searched PubMed, Web of Science, Scopus, and Google 
Scholar for research articles published from Jan 1, 2000, to 
Dec 31, 2019. The search terms comprised “projection”, 
“temperature”, and “diarrhoea”. We also expanded the search 
in Google to consider non-research articles and unpublished 
materials. Projections of global temperature-attributable 
mortality due to enteric infections have been generated 
previously using all-cause infections; however, enteric 
infections have varying temperature sensitivities, depending 
on their cause. Studies generally found that bacterial 
pathogens have positive associations with ambient 
temperature, whereas viral pathogens have negative 
temperature associations. One study in Japan suggested that 
reductions in the number of temperature-related viral enteric 
infections could cause net reductions in the overall number of 
temperature-attributable enteric infections. Another study in 
an Indian city projected a net increase in excess temperature-
attributable enteric infections despite reductions in rotavirus 
prevalence. Global-level projections of temperature-
attributable enteric infection mortality might be improved if 
various pathogens were considered separately according to 
their temperature sensitivities.
Added value of this study
This study showed that most temperature-attributable excess 
deaths due to enteric infections might be caused mainly by 
shigellosis, cryptosporidiosis, and typhoid fever. Reductions in 
temperature-attributable deaths might be from a decrease in 
cases of rotaviral and noroviral enteritis. Most global 
temperature-attributable excess enteric infection deaths are 
projected to occur in sub-Saharan Africa and South Asia across 
all sociodemographic and climate change scenarios. Net 
reductions might occur in Latin America and the Caribbean as 
well as East Asia and the Pacific under optimistic scenarios of 
sociodemographic development and effective climate change 
mitigation.
Implications of all the available evidence
Global temperature-attributable deaths in the future could be 
reduced by supporting climate change mitigation policies on a 
global level as well as socioeconomic development and health 
adaptation for low-income and middle-income countries.
ln[E(Dr,l,a,t)]=αr,l,a + β0SDI<0·8,l,t + β1SDI≥0·8,l,t + θ at + ln(Sl,a,t)
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β0, β1, and θ denote the parameters of estimation. The 
model was fitted using data from 1990–2005 
(appendix pp 3–4), and projections were generated for 
2006–2100 (appendix pp 5–7).
We obtained the 1990–2005 pathogen-specific enteric 
infection mortality rates (D) from the IHME-GBD, 
which we used as baseline values for D.23 On the basis of 
existing evidence for their associations with ambient 
temperature, the following ten enteric pathogens 
were selected: non-typhoidal salmonella, Shigella, 
Campylobacter, cholera, enteropathogenic E coli, entero-
toxigenic E coli, typhoid, rotavirus, norovirus, and 
Cryptosporidium.24 The selected pathogens accounted 
for 85% of the overall enteric infections described in the 
IHME-GBD. The mortality rate data (expressed 
per 100 000 of population) were reported in five age 
groups and 179 countries. We grouped the countries by 
World Bank regions: sub-Saharan Africa, South Asia, 
East Asia and the Pacific, Latin America and 
the Caribbean, North America, Europe and Central Asia, 
and Middle East and North Africa.
The SDI was based on the gross domestic product per 
capita,25,26 mean years of schooling per capita in the 
population aged 25 years and older, and total fertility rate 
per capita in the population aged 15–25 years,27,28 which 
were projected according to shared socioeconomic 
pathways (SSPs) 1, 2, and 3 (appendix p 5). SSPs are 
scenarios that depict different narratives of future 
scenarios: SSP1 depicts a future of sustainability with 
low challenges in mitigation and adaptation; SSP2 is the 
middle of the road scenario, which generally follows 
historical trends; and SSP3 describes a divided and 
unstable future with high challenges in mitigation and 
adaptation.29 Mitigation refers to actions related to 
reducing greenhouse gas emissions thereby limiting 
global warming and its related effects, while adaptation 
refers to adjustments in socioeconomic systems in 
response to expected effects of climate change.
The scalar of risk factors S was a combination of the 
non-pathogen-specific population-attributable fractions 
of unsafe sanitation, no access to handwashing facilities, 
underweight children, child wasting, child stunting, 
vitamin A deficiency, and zinc deficiency.30 Projections of 
these scalars were based on the weighted annualised rate 
of change (AROC) by country and age group 
(appendix p 6).22 Three scenarios were derived using 
pooled AROCs: (1) baseline health investment (BHI) was 
the reference AROC; (2) additional health investment 
(AHI) was based on the 85th percentile AROC; 
and (3) lowered health investment (LHI) was based on 
the 15th percentile AROC.22 The AHI scenario depicts 
faster reductions of exposure to the risk factors, whereas 
the LHI scenario has slower reductions over time. The 
BHI scenario follows the historical trends of each country 
and age group. We paired the health investment scenarios 
according to the SSP narratives that they are aligned 
with.29 The main scenario com binations were SSP1-AHI 
(termed optimistic), SSP2-BHI (intermediate), and SSP3-
LHI (pessimistic). We also ran all possible scenarios for 
comparison: SSP1-BHI, SSP2-AHI, SSP2-LHI, and 
SSP3-BHI. This process was to test the sensitivity of 
assuming different health investments under the same 
SSP scenario.
Mortality counts were quantified as 16-year means 
(1990–2005, 2020–35, 2050–65, and 2080–95) and are 
presented at global level and for each World Bank region. 
To derive alternative forecasts of baseline mortality rates, 
used in sensitivity analyses, we used the Mathers and 
Loncar model, which uses gross domestic product, mean 
years of schooling, and trend without any scalar of risk 
factors (appendix p 7).31 We validated the models using 
the out-of-sample root mean squared error (appendix p 7).
Temperature-attributable enteric infection mortality 
estimation
We estimated the annual number of temperature-
attributable enteric infection deaths from the baseline 
enteric infection mortality rates using the product of 
temperature anomalies and pathogen-specific temp-
erature sensitivity as follows:15
where d is the temperature-attributable enteric infection 
mortality, D is the baseline enteric infection mortality 
rates derived from the first stage, P is the population, β is 
the pathogen-specific mortality change per 1°C increase 
in temperature, and T is the annual mean temperature.
To convert the mortality rates into the numbers of 
deaths, we used population projections for SSPs 1, 2, 
and 3 from the Intersectoral Impact Model Inter-
comparison Project 2b (ISIMIP2b),32 which are related to 
the projections of several SDI components.27,33 We 
assumed that the mortality rates applied to the whole 
country so we multiplied the rates with the population 
projection in the appropriate grid cells within each of the 
179 country boundaries.
The β values were derived from a previous meta-
analysis (appendix p 10).24 We assumed that the short-
term temperature-morbidity associations were applicable 
to annual-level mortality outcomes.15
The annual temperature anomaly was calculated by 
subtracting the mean near surface air temperature during 
1976–2005 from the projected annual near surface air 
temperatures during 2006–99 with use of 0·5° × 0·5° grid 
cells. Near surface air temperature data were obtained 
from ISIMIP2b,32 and they corresponded to the downscaled 
and bias-corrected Coupled Model Intercomparison 
Project phase 5 simula tions from four global climate 
models (GCMs), namely GFDL-ESM2M, HadGEM2-ES, 
IPSL-CM5A-LR, and MIROC5.34 They are modelled 
according to mitigation scenarios called representative 
concentration pathways (RCPs), which report radiative 
See Online for appendix
dr,l,t=Dr,l,a,t × Pl,a,t ×
e[β r × (Tprojected – Tbaseline)] – 1
e[β r × (Tprojected – Tbaseline)]
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forcing in watt per square metre by 2100.35 Since the 
pairings between RCPs and SSPs are based on the specific 
SSP narrative, which can theoretically produce the 
radiative forcing levels, we limited the analysis to only 
RCP2.6, 4.5, and 6.0. RCP2.6 represents high mitigation 
response, whereas RCP4.5 and 6.0 depict lesser mitigation 
and more reliance on non-renewable sources emitting 
more greenhouse gas emissions.
Statistical analysis
All RCPs were pairable with the optimistic (SSP1-AHI) 
and intermediate (SSP2-BHI) scenarios, whereas only 
RCPs 4.5 and 6.0 were paired with the pessimistic 
scenario (SSP3-LHI; appendix p 11).29 We also ran all 
possible combinations of SSPs and health investment 
scenarios for comparison. We presented the mean 
annual number of temperature-attributable enteric 
infection deaths by the selected 16-year periods (2020–35, 
2050–65, and 2080–95).
We used a bootstrapping approach to account for the 
uncertainty related to different GCMs and β values. Spe-
cifically, we generated 1000 estimations of temperature-
attributable enteric infection deaths per GCM, by drawing 
from the Gaussian distribution defined by the central 
β estimates and their SEs.36 The 95% empirical CIs (eCIs) 
were determined from the 2∙5th and 97∙5th percentiles 
of the bootstrapped sample, pooling estimates across 
GCMs.
We also derived the temperature-attributable fractions 
by dividing the projected mean temperature-attributable 
deaths by the projected baseline mean deaths according 
to pathogen. The attributable fractions to temperature 
generally show the percentage change produced by the 
β values and temperature anomalies. To further explore 
the changes from the β values and temperature 
anomalies, we analysed no population change scenarios 
since the baseline year of 2005.
In addition to pathogen-specific results, we also derived 
attributable mortality estimates aggregated across taxa 
and across all pathogens (all-cause) using the pooled 
estimates of temperature sensitivity values from a 
2020 meta-analysis.24 This approach is to observe how 
different the pathogen-specific projections will be 
compared with simpler approaches of taxa-specific and 
all-cause.
All analyses were done using R programming, 
version 4.0.2.37 We ran the model using lme4 package and 
derived the 95% eCIs with the fitdistrplus package.38,39 
Reproducible codes are available in the lead author’s 
GitHub and all outputs are available in the ISIMIP data 
archive.32
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report.
Results
We projected that across all scenarios the mean annual 
number of global deaths from enteric infections would 
decrease from the 1 864 355 in 1990–2005 to 414 871 under 
the intermediate scenario (SSP2-BHI), 196 296 under the 
optimistic scenario (SSP1-AHI), and 1 051 819 under the 
pessimistic scenario (SSP3-LHI) in 2080–95 (appendix 
pp 12–20). The change was greatest under the optimistic 
scenario and smallest under the pessimistic scenario. In 
terms of health investment scenarios, the number of 
deaths increased in LHI and decreased in AHI with BHI 
as a reference under all SSPs (appendix p 21). Rotaviral 
enteritis, shigellosis, and cryptosporidiosis were the 
three main pathogens predicted to contribute to the total 
number of global enteric infection deaths, accounting 
Figure 1: Global climate model-ensemble estimates of mean global temperature-attributable enteric 
infection deaths by pathogen and all-cause under various scenarios
Filled circles indicate net change across all pathogens and whiskers show 95% empirical CIs. An additional figure 
with a varying y-axis range is shown in the appendix (p 35). E coli= Escherichia coli. SSP=shared socioeconomic 
pathway. BHI=baseline health investment. AHI=additional health investment. LHI=lowered health investment. 
RCP=representative concentration pathway. 
RCP2.6 RCP4.5
Climate change scenarios Climate change scenarios Climate change scenarios
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For reproducible codes see 
https://github.com/paulcarlos
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for 60% of future enteric infection deaths in 2080–95 
under the inter mediate scenario. Non-typhoidal 
salmonellosis, entero pathogenic E coli enteritis, and 
enterotoxigenic E coli enteritis account for the three 
smallest proportions of enteric infection deaths over the 
years. Across all scenarios, the regions with the most 
deaths were sub-Saharan Africa and South Asia, whereas 
those with the lowest were Europe and Central Asia and 
North America.
Mean annual global temperature anomalies were gen-
erally low in 2020–35. In 2050–65, the mean temperature 
anomalies were higher compared with 2020–35 and were 
highest under RCP4.5. By 2080–95, the mean temperature 
anomalies were increasing by radiative forcing at 1∙85°C 
(range 1∙10–2∙45) under RCP2.6, at 3∙04°C (1∙84–4∙17) 
under RCP4.5, and at 3∙71°C (2∙68–4∙96) under RCP6.0. 
The Europe and Central Asia region was expected to have 
the largest positive temperature anomalies, whereas the 
smallest anomalies were expected in Latin America and 
the Caribbean (appendix p 22).
The mean number of global temperature-attributable 
deaths under the intermediate scenario is expected to 
decrease from 37 508 (95% eCI 36 266–38 751) in 2020–35 
to 29 786 (25 666–33 906) in 2080–95 under RCP4.5 
(figure 1, appendix pp 23–29). The temperature-attributable 
fractions, by contrast, will increase from 3∙85% (95% eCI 
3∙72–3∙98) in 2020–35 to 7∙18% (6∙19–8∙17) in 2080–95 
under RCP4.5 (figure 2). With no population change, 
the mean number of temperature-attributable deaths 
were generally lower with an estimated 15 694 deaths 
(95% eCI 14 744–16 644) under the intermediate scenario 
and RCP4.5 (appendix p 30).
Shigellosis, cryptosporidiosis, and typhoid were the 
pathogens with the most projected temperature-
attributable excess deaths and temperature-attributable 
fractions. Under RCP4.5, in 2080–95, shigellosis will 
account for 15 978 (95% eCI 13 030–18 925), crypto-
sporidiosis for 12 955 (9935–15 976), and typhoid for 
6897 (5217–8577) temperature-attributable enteric 
infection deaths. The least attributable deaths and 
fractions are expected from enteropathogenic 
E coli enteritis, enterotoxigenic E coli enteritis, and 
campylobacteriosis.
We observed reductions in the number of temperature-
attributable deaths in 2080–95 of –11 803 (95% eCI 
–3863 to –19 743) for rotaviral enteritis and –9273 
(–4871 to –13 676) for noroviral enteritis under RCP4.5. The 
smallest temperature-attributable fractions were from 
noroviral enteritis. In general, the reductions showed a 
decreasing trend under RCP2.6 and an increasing trend 
under RCP6.0. Between 2080 and 2095, a higher number 
of temperature-attributable deaths and fractions can be 
expected as radiative forcing increases.
The number of temperature-attributable enteric infec-
tion deaths under the optimistic scenario was lower than 
that under the intermediate scenario, with the lowest 
estimates under RCP2.6 at 20 915 (95% eCI 20 157–21 674) 
in 2020–35, 10 023 (9178–10 867) in 2050–65, and 
6599 (5441–7757) in 2080–95. This optimistic scenario 
also produces similar patterns for the pathogen 
composition under the intermediate scenario, with 
shigellosis con tributing the most to excess deaths, and 
rotaviral enteritis having the largest reduction in 
temperature-attributable enteric infection deaths. Under 
the pessimistic scenario, more temperature-attributable 
enteric infection deaths are estimated than with the 
intermediate scenario. The pessimistic scenario also 
yields increasing numbers of temperature-attributable 
enteric infection deaths over time, unlike the optimistic 
and intermediate scenarios. The number of temperature-
attributable enteric infection deaths were 54 081 
(95% eCI 52 922–55 240) in 2020–35, 74 844 (68 409–81 280) 
RCP2.6 RCP4.5
Climate change scenarios Climate change scenarios Climate change scenarios
2020−35 2050−65 2080−95
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Figure 2: Global climate model-ensemble estimates of mean global temperature-attributable fractions of 
enteric infection deaths by pathogen under various scenarios
Whiskers show 95% empirical CIs. Alternate figures with a varying y-axis range are shown in the appendix 
(pp 36–38). E coli= Escherichia coli. SSP=shared socioeconomic pathway. BHI=baseline health investment. 
AHI=additional health investment. LHI=lowered health investment. RCP=representative concentration pathway. 
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in 2050–2065, and 83 888 (67 760–100 015) in 2080–2095 
under RCP6.0.
Most of the estimated global temperature-attributable 
deaths due to enteric infections are from the sub-Saharan 
Africa and South Asia regions (figure 3). Between 2080 
and 2095, the mean number of temperature-attributable 
enteric infection deaths in sub-Saharan Africa could be as 
low as 4538 (95% eCI 4325–4751), as projected under the 
optimistic scenario and RCP2.6, or could be as high 
as 60 001 (52 224–67 778), as projected under the 
pessimistic scenario and RCP6.0. Under the inter mediate 
scenario and RCP4.5, most temperature-attributable 
enteric infection deaths in sub-Saharan Africa in 2080–95 
are projected to be from cryptosporidiosis (11 999 
[95% eCI 9196–14 801]) and shigellosis (10 648 
[8689–12 607]). The mean number of temperature-
attributable enteric infection deaths in South Asia 
in 2080–95 is projected to be 1871 (95% eCI 1367–2375) 
under the optimistic scenario and RCP2.6 or 22 014 
(16 861–27 168) under the pessimistic scenario and 
RCP6.0. Low numbers of temperature-attributable enteric 
infection deaths in 2080–95 were projected for the Europe 
and Central Asia and North America regions, especially 
under the optimistic scenario and RCP2.6 with 47 
(95% eCI 21–73) for Europe and Central Asia and 
nine (1–19) for North America. The Middle East and 
North Africa was projected to have 1044 deaths (95% eCI 
538–1551) under the pessimistic scenario and RCP6.0. 
Without population change, mean temperature-
attributable deaths were lower than with population 
change especially in sub-Saharan Africa (appendix p 39).
Net reductions in the number of enteric infection deaths 
are projected in East Asia and the Pacific and Latin America 
and the Caribbean. East Asia and the Pacific showed 
reductions in 2080–95 under the optimistic scenario and 
RCP2.6 (–98 [95% eCI –630 to 433]) but not under the 
pessimistic scenario and RCP6.0 (949 [–903 to 2802]). 
Projections also suggested that Latin America and 
the Caribbean could see reductions in the number of 
enteric infection deaths in 2080–95 of up to –223 (95% eCI 
–961 to 514), as estimated under the pessimistic scenario 
and RCP6.0, or as little as –47 (–173 to 79), as estimated 
under the optimistic scenario and RCP2.6. The net 
reductions for both regions result from decreases in the 
numbers of rotaviral and noroviral enteritis deaths.
The estimated numbers of global temperature-
attributable enteric infection deaths calculated by taxa-
specific and all-cause temperature sensitivity are similar 
to the pathogen-specific estimates (figure 4). Under the 
intermediate scenario and RCP4.5, in 2080–95, the mean 
number of temperature-attributable enteric infection 
deaths estimated according to taxa-specific temperature 
sensitivity is 35 023 (95% eCI 32 572–37 474), and that 
estimated according to the all-cause approach is 31 391 
(23 382–39 400), both of which are higher than the 
estimate based on the pathogen-specific approach. 
However, the region-specific estimates of temperature-
attributable enteric infection death vary according to 
approach (appendix pp 40–46). The num bers of 
temperature-attributable enteric infection deaths derived 
using the Mathers and Loncar model were lower under 
SSP2 and SSP3, but were higher under SSP1 
in comparison to those derived using Foreman and 
colleagues’ model (appendix p 47).22
Discussion
We estimated the global temperature-attributable mortality 
due to enteric infections under various sociodemographic 
and climate scenarios, up to 2099. For the first time to our 
knowledge, we considered the different effects of 
temperature on major enteric pathogens. Our findings 
Figure 3: Global climate model-ensemble estimates of mean temperature-attributable enteric infection 
deaths under various scenarios in 2080–95 by 0·5° × 0·5° grids
E coli= Escherichia coli. SSP=shared socioeconomic pathway. BHI=baseline health investment. AHI=additional health 
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showed that the number of global temperature-related 
excess deaths due to enteric infections could increase 
under the pessimistic sociodemographic and health 
investment scenarios, despite considerable reductions in 
the number of deaths from viral pathogens. Conversely, 
fewer temperature-related excess deaths are predicted to 
occur under a future with optimistic sociodemographic 
growth and health invest ments. This result is consistent 
with the findings from previous global projections of 
diarrhoeal mortality in children in which poor 
socioeconomic growth was found to slow down the 
reductions.15 We also found that a future with a warmer 
climate might have higher enteric infection mortality 
compared with a future in which there is less warming.40,41
Our projections suggest that temperature-related excess 
deaths will mainly be caused by Shigella, Cryptosporidium, 
and Salmonella enterica serovar Typhi. These entero-
pathogens are already a substantial burden in LMICs.42 
Shigellosis was estimated as the second leading cause 
and cryptosporidiosis was estimated as the fifth leading 
cause of diarrhoea mortality in 2016, which predominantly 
affects young children and older populations.43,44 Similarly, 
typhoid fever was estimated to cause substantial mortality 
in young children in 2017.45 These pathogens are generally 
transmitted person to person via the faecal–oral route.42 
The former two diseases are common causes of moderate 
to severe diarrhoea in young children, which can be 
fatal.46 These pathogens are projected to cause excess 
deaths attributable to ambient temperature because their 
transmissions in the future could be exacerbated by 
warmer climate via extended bioavailability through 
environmental or animal reservoirs,13,47 food spoilage,6,48 or 
contaminated drinking water.2 Sustaining the current 
approaches for water, sanitation, and hygiene as well as 
child nutrition, together with the possible development of 
vaccines, would help prevent infections and deaths from 
these pathogens.49,50
We projected that increasing global temperatures 
would lead to a reduction in deaths from rotavirus and 
norovirus. This finding diminished the overall attri-
butable enteric infection deaths, especially in futures 
characterised by unfavourable sociodemographic 
development and warmer climate. In the Latin America 
and the Caribbean and East Asia and the Pacific regions, 
the reductions in the number of temperature-attributable 
enteric infection deaths from viral pathogens led to net 
reductions in the number of temperature-attributable 
enteric infection deaths from all-cause enteric infections. 
This result is in agreement with the findings of a 
projection study of infectious gastroenteritis done in 
Japan wherein net reductions were found to occur owing 
to a considerable decrease in cold-related morbidity, 
which might have been associated with viral pathogens.16 
Rotavirus is the leading cause of diarrhoea mortality in 
all age groups, but particularly in young children.20 As 
with many enteropathogens, rotavirus and norovirus 
are primarily transmitted via the faecal–oral route or via 
contaminated food or water.42 Unlike some bacteria, 
viral pathogens have lower survival in food, water, and 
other surfaces as the temperature increases,51,52 explaining 
their future reductions in temperature-attributable deaths. 
However, reductions in the number of temperature-
attributable deaths from rotavirus could be less important 
in futures with sustained rotavirus vaccination and 
the introduction of rotavirus vaccination to countries 
currently without, which could drastically reduce baseline 
mortality from rotavirus.22
Warmer temperatures might bring a more suitable 
environment for the growth and survival of some 
bacterial enteropathogens such as Salmonella, Shigella, 
Campylobacter, and E coli,53–56 supporting the projected 
increase in deaths under futures with substantial warm-
ing. However, this is not the case for Cryptosporidium, 
which has reduced survival under warmer temperatures, 
especially beyond 15°C.57,58 A possible explanation would 
be that milder winter temperatures could bring more 
suitable ambient tem peratures for survival. Additionally, 
numerous pathways related to warmer temperatures can 
Figure 4: Global climate model-ensemble estimates of global temperature-attributable enteric infection 
deaths by temperature-sensitivity approach
Whiskers show 95% empirical CIs. SSP=shared socioeconomic pathway. BHI=baseline health investment. 
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explain the increase in Cryptosporidium cases. Ikiroma 
and Pollock suggested that changes in human activities 
such as swimming in untreated freshwater streams and 
lakes, increased demand for drinking water, and less 
conscientious hygiene might promote infections with 
Cryptosporidium during warmer temperatures.59 
Additionally, Lake and colleagues postulated that overflow 
from animal reservoirs might be responsible for the 
increased Cryptosporidium infections during early summer 
months.60 The authors found asso ciations between river 
flow and cryptosporidiosis during April to July, which 
might be explained by the release of large numbers of 
highly infectious newborn farm animals onto land from 
which their excrement could readily be washed into 
freshwater bodies.60,61 Ultimately, the complex processes 
behind the biological, social, and environmental 
transmissions make the association for a specific pathway 
very difficult to pinpoint, not only for Cryptosporidium but 
for all enteropathogens.
The pathogen-specific approach showed that the 
regions of concern remain sub-Saharan Africa and 
South Asia, similar to the previous projection study.15 
Most of the global burden of enteric infections was still 
from these regions because there were more non-viral 
infections that were sensitive to temperature increases 
unlike the Latin America and the Caribbean or East Asia 
and the Pacific regions, which had more viral infections. 
Generally, a low number of deaths was found in other 
regions like the Middle East and North Africa, Europe 
and Central Asia, and North America. Results showing 
net reductions in some regions were not generated 
when all-cause or taxa-specific approaches in estimating 
temperature-attributable mortality were applied. The 
result could mean that this approach reveals smaller 
geographical locations that require more attention in 
terms of their medical management of enteric infections 
and other necessary means to control the transmission of 
enteropathogens.
This study has some major caveats. First, the pathogen-
specific relative risks (RRs; mortality change per 1°C 
increase in temperature) that we used are subject to 
some assumptions and uncertainty. We assumed that 
daily or weekly temperature-enteric infection associations 
were applicable to annual-level mortality and that they 
remained constant over the years. However, the 
associations between annual temperature and annual 
mortality might be different and could change over time. 
We also assumed that a single RR per pathogen from the 
meta-analysis would capture the mean risk for all 
locations. This assumption might not be the case because 
various geographical areas have different physical 
characteristics like climate, urbanisation, population 
density, and altitude, among others that could affect 
pathogen distribution and transmission. It should also 
be noted that the pathogen-specific RRs derived from the 
studies found in a separate systematic review and meta-
analysis had limitations.24 For some of the pathogens like 
typhoid, norovirus, and cryptosporidiosis, estimates were 
based on only a few studies. Moreover, the RR for 
shigellosis was derived mainly from studies in China, 
which might not be representative of other locations. 
Second, we were not able to incorporate the effect of 
vaccinations into the model. Vaccinations against 
rotavirus could further accelerate reductions in mortality 
from rotaviral enteritis, especially in countries where the 
rotavirus vaccine is not yet administered.62 It is worth 
noting that this scenario could be captured to some 
extent in projections for sociodemographic development. 
Accelerated vaccination could change the proportions of 
pathogens that we assumed were constant. Third, 
although we accounted for uncer tainties inherent in 
GCMs and RRs, we were not able to consider several 
other sources of uncertainty. These include uncertainties 
from the modelled pathogen-specific mortality data from 
IHME-GBD, the prediction of base line mortality, and the 
projection of sociodemographic development and scalar 
of risk factors. Since we were not able to consider other 
sources of uncertainty, the projected estimates might 
have wider uncertainties than what were presented. 
Fourth, the projections of future scalar of risk factors for 
enteric infections were not based on SSPs. Modelling 
future scenarios of water, sanitation, and hygiene as well 
as nutrition within SSPs might help improve projections 
of health outcome and diseases like enteric infections. 
Lastly, given the empirical evidence currently available, 
we were only able to incorporate temperature as one 
pathway through which climate change might affect 
enteric infections. Humidity, rainfall, drought, flooding, 
and El Niño–Southern Oscillation affect the transmis-
sion of enteric infections but modelling them remains 
a challenge especially in large geographical areas. 
The results of this study should be interpreted as 
temperature-attributable mortality, which should be a 
part of the excess mortality due to climate change. Future 
projections of enteric infections should attempt to 
incorporate other factors.
In summary, shigellosis, cryptosporidiosis, and typhoid 
were projected to have the largest contributions to global 
temperature-attributable deaths due to enteric infections, 
outweighing projected reductions in the number of such 
deaths from viral pathogens. Net excess deaths due to 
enteric infections could increase under a future with a 
warmer climate and pessimistic sociodemographic 
development. It would be beneficial to support mitigation 
policies that limit global warming and to promote 
sociodemographic development for LMICs.
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